For scaling drug plasma clearance (CLp) from adults to children, extrapolations of population pharmacokinetic (PopPK) covariate models between drugs sharing an elimination pathway have enabled accelerated development of pediatric models and dosing recommendations. This study aims at identifying conditions for which this approach consistently leads to accurate pathway specific CLp scaling from adults to children for drugs undergoing hepatic metabolism. A physiologically based pharmacokinetic (PBPK) simulation workflow utilizing mechanistic equations defining hepatic metabolism was developed. We found that drugs eliminated via the same pathway require similar pediatric dose adjustments only in specific cases, depending on drugs extraction ratio, unbound fraction, type of binding plasma protein, and the fraction metabolized by the isoenzyme pathway for which CLp is scaled. Overall, between-drug extrapolation of pediatric covariate functions for CLp is mostly applicable to low and intermediate extraction ratio drugs eliminated by one isoenzyme and binding to human serum albumin in children older than 1 month.

Additional Metadata
Persistent URL dx.doi.org/10.1002/psp4.12273, hdl.handle.net/1765/104431
Journal CPT: Pharmacometrics and Systems Pharmacology
Citation
Calvier, E.A.M. (Elisa A. M.), Krekels, E.H.J, Yu, H. (Huixin), Välitalo, P.A.J, Johnson, T.N, Rostami-Hodjegan, A, … Knibbe, C.A.J. (2018). Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments. CPT: Pharmacometrics and Systems Pharmacology. doi:10.1002/psp4.12273